According to a questionnaire sent to Designated Cancer Care Hospitals in Japan in 2013, only 39.4% of the institutes had medical oncology departments. Furthermore, most of these medical oncology departments were primarily responsible for the treatment of limited disease categories and the administration of newly developed therapeutic modalities, including molecular-targeted therapy. The aim of the present study was to update these previous findings and to clarify the changes over the intervening 7-year period.

中文翻译：

---

日本肿瘤内科现状及最近7年的变化：向指定癌症诊疗医院发送的问卷调查结果

根据 2013 年发给日本指定癌症护理医院的调查问卷，只有 39.4% 的机构设有肿瘤内科。此外，这些肿瘤内科部门中的大多数主要负责有限疾病类别的治疗和新开发的治疗方式的管理，包括分子靶向治疗。本研究的目的是更新这些先前的发现，并阐明其间 7 年间的变化。